Kit, reaction system and method for detecting gene copy number variation in a sample
Through multiple amplification reaction system and bioinformatic analysis, the problems of high cost and low accuracy of gene copy number variation detection in the prior art are solved, and efficient and accurate gene copy number variation detection is achieved, which simplifies experimental steps and improves the Detection consistency.
Patent Information
- Application Number
- CN202111056562.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-09
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2041-09-09
AI Technical Summary
The existing gene copy number variation detection technology based on the NGS platform has problems such as high sequencing cost, low accuracy and complex experimental steps, especially the hybridization capture technology requires multiple customized probes and complex operations.
Using a multiple amplification reaction system, the upstream, middle and downstream regions of the target gene were designed to cover the upstream, middle and downstream regions of the target gene, optimize the reaction conditions, and build a baseline training set of negative and positive samples, and perform bioinformatic analysis of the sequencing data, combining tumor cells of tumor FFPE samples. Integrated content interpretation reduces probe synthesis and experimental steps for multiple target gene regions.
The detection cost is reduced, the throughput and accuracy of CNV detection of specific genes is improved, and the consistency of the detection results with hybridization capture technology has increased from 83.3% to 100%, reducing the background baseline deviation of amplification preference and over-amplification introduction.
Smart Images

Figure BDA0003254807850000061 
Figure BDA0003254807850000071 
Figure BDA0003254807850000072
Abstract
Description
Technical Field
[0001] The present invention relates to the field of in vitro diagnostic reagents, and in particular to a reaction system and method for detecting gene copy number variation in a sample. Background Art
[0002] Copy Number Variation (CNV) is a part of structural variation (SV). It is caused by genome rearrangement and generally refers to the increase or decrease in the copy number of large genomic fragments with a length of more than 1kb, mainly manifested as deletions and duplications at the submicroscopic level. Studies have found that copy number variations of some common specific genes are associated with the prognosis of various tumors and the sensitivity of targeted drugs. Therefore, accurate and reliable CNV test results can provide a reference for the diagnosis and treatment of diseases.
[0003] At present, the target gene CNV detection technology based on the NGS platform mainly includes whole genome sequencing and hybridization capture technology. Since the human genome is too large, whole genome sequencing requires a large amount of sequencing and a certain sequencing depth to meet the accuracy of CNV detection of specific genes, which has led to a significant increase in sequencing costs and a decrease in the accuracy of CNV detection results due to the inability to achieve sufficient sequencing depth.
[0004] Hybridization capture technology uses probes customized for the target genomic region to hybridize with genomic DNA, enrich the DNA in the target gene region, and then perform NGS sequencing. Usually, the length of the customized probe is 120nt, and biotin needs to be added for labeling. For CNV detection of a target gene region, multiple probes generally need to be designed. Therefore, synthesizing probes for multiple regions of multiple target genes at the same time leads to an increase in detection costs. In addition, the experimental steps of hybridization capture technology are relatively more and the operation is more complicated.
[0005] The information in the background technology is only for illustrating the general background of the present invention and should not be regarded as admitting or suggesting in any form that such information constitutes the prior art known to a person skilled in the art. Summary of the invention
[0006] To solve the technical problems existing in the prior art, the present invention provides a multiple amplification reaction system for detecting specific gene copy number variation (CNV). By designing primers for the genomic regions of multiple target genes, the primers evenly cover the upper, middle and downstream regions of the target gene genome, and realize multiple amplification of the regions of the designed primers at the same time. In the detection method of the present invention, the amplified regions of the target gene are optimized and screened at the same time, and the regions respectively located in the upper, middle and downstream of the target gene are obtained as the optimal set of target gene CNV detection regions. In addition, a reaction system suitable for the detection method of the present invention is obtained by multiple optimization. In addition, by constructing negative and positive sample baseline training sets, the sequencing data is subjected to bioinformatics analysis and CNV baseline division. Based on bioinformatics analysis and combined with the tumor cell content of tumor FFPE samples, the copy number changes of specific genes in the samples are integrated and interpreted. Specifically, the present invention includes the following contents.
[0007] In a first aspect of the present invention, a method for detecting gene copy number variation in a sample is provided, comprising the following steps:
[0008] (1) selecting a genomic sequence corresponding to a target gene, designing multiple pairs of primers with evenly distributed target regions of 75-150 bp, preferably 80-120 bp, for the genomic sequence, and forming a primer set consisting of the multiple pairs of primers, wherein the genomic sequence includes an upstream sequence, a downstream sequence, and an exon and / or intron sequence of the target gene;
[0009] (2) constructing a multiplex amplification reaction system using the primer set, and optimizing the reaction conditions to obtain multiplex amplification products;
[0010] (3) performing end repair on the obtained multiple amplification products, connecting sequencing adapters, and obtaining a sequencing library through PCR amplification and enrichment for sequencing;
[0011] (4) constructing negative and positive sample baseline training sets and analyzing sequencing data to obtain CNV baselines; and
[0012] (5) Interpret the sequencing results based on the CNV baseline.
[0013] According to the method for detecting gene copy number variation in a sample, preferably, the upstream sequence includes a region extending 1-50bp from the start codon of the target gene to the 5' side, preferably 1-40bp, and further preferably 5-20bp, and the downstream sequence includes a region extending 1-50bp from the stop codon of the target gene to the 3' side, preferably 1-40bp, and further preferably 5-20bp.
[0014] According to the method for detecting gene copy number variation in a sample, preferably, the reaction system comprises primers mixed in equal proportions.
[0015] According to the method for detecting gene copy number variation in a sample, preferably, the optimized reaction conditions include a first cycle and a second cycle; wherein the first cycle includes the step of repeating a high temperature reaction and a first low temperature reaction for n times, and the second cycle includes the step of repeating a high temperature reaction and a second low temperature reaction for m times, wherein n and m are each a natural number between 5 and 20, preferably 6-15, and further preferably 7-13. The high temperature refers to 95-99°C, preferably 96-98°C, and preferably 96-97°C. The first low temperature refers to a temperature between 50-70°C, and preferably 50-65°C, 52-60°C. And in the first cycle, the first low temperature of each cycle decreases in sequence, and the second low temperature is the temperature corresponding to the nth cycle.
[0016] According to the method for detecting gene copy number variation in a sample, preferably, the gene copy number variation includes the copy number change of the entire genomic region corresponding to the target gene.
[0017] According to the method for detecting gene copy number variation in a sample, preferably, the number of the target genes is 2-100, further preferably 10-100, and further preferably 50-100.
[0018] According to the method for detecting gene copy number variation in a sample, preferably, each primer in the primer set does not contain a modification and / or a label.
[0019] According to the method for detecting gene copy number variation in a sample, preferably, the number of primer pairs in the primer set is 5-1000, further preferably 10-1000, and further preferably 50-100.
[0020] According to the method for detecting gene copy number variation in a sample, preferably, the sample is peripheral blood, a tumor FFPE sample or a fresh tissue sample.
[0021] In a second aspect of the present invention, a kit for detecting gene copy number variation in a sample is provided, comprising a primer set consisting of multiple pairs of primers, wherein the primer set comprises multiple pairs of primers with evenly distributed target regions of 75-150 bp respectively designed for the genomic sequence corresponding to the target gene, wherein the genomic sequence includes the upstream sequence, downstream sequence and exon and / or intron sequence of the target gene.
[0022] The third aspect of the present invention provides a reaction system for detecting gene copy number variation in a sample, characterized in that it comprises a primer set and a buffer, wherein the primer set consists of multiple pairs of primers, and the multiple pairs of primers are obtained by selecting a genomic sequence corresponding to a target gene, and designing multiple pairs of primers with respective target regions of 75-150 bp, each evenly distributed, for the genomic sequence, wherein the genomic sequence includes an upstream sequence, a downstream sequence, and exon and / or intron sequences of the target gene.
[0023] The present invention uses unmodified primers to perform multiple PCR amplification on multiple regions of multiple target genes, reducing the high cost investment and cumbersome experimental operation process caused by synthesizing probes for multiple regions in other CNV detection technologies such as hybridization capture technology. In addition, primers are designed only for the upper, middle and downstream regions of the target gene, and a training set is constructed through negative and positive samples to perform CNV integration interpretation. There is no need to design additional balanced primers across the entire genome. At the same time, by optimizing the multiple amplification reaction system, background baseline deviation introduced by amplification preference or over-amplification is prevented, and the copy number variation information of the original template is well preserved.
[0024] In summary, the present invention not only reduces the investment in detection costs, but also improves the throughput and accuracy of CNV detection of specific genes in samples, such as tumor FFPE samples. According to the test results of tumor FFPE samples before and after the optimization of the multiple amplification reaction system, the consistency of CNV detection between the method of the present invention and the hybrid capture technology was improved from 83.3% before optimization to 100%. DETAILED DESCRIPTION
[0025] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0026] It should be understood that the terms described in the present invention are only for describing special embodiments and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that the upper and lower limits of the scope and each intermediate value therebetween are specifically disclosed. Each smaller range between the intermediate value in any stated value or stated range and any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0027] Unless otherwise specified, all technical and scientific terms used herein have the same meanings as commonly understood by those skilled in the art. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials related to the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail. Unless otherwise specified, "%" is a percentage based on quantity.
[0028] In the detection method of the present invention, primers are designed for the genome corresponding to the target gene, and the region covered by the primers includes exons and introns, as well as the upstream and downstream regions of the target gene, so as to analyze the copy number changes of the entire genomic region of the target gene. The amplified region of the target gene is optimized and screened, and the region with a coverage of 100 times and amplification efficiency stability can be retained through multiple rounds of test experimental results. In a specific embodiment, the target gene and primer sequences listed in the detection method of the present invention are only exemplary and should not be regarded as restrictive. Those skilled in the art can select the target gene or target gene and design corresponding primers as needed.
[0029] The method of the present invention includes obtaining a reaction system suitable for the detection method of the present invention through multiple optimizations, further reducing the influence between multiple primer pairs, and the optimization parameters include but are not limited to annealing temperature, amplification cycle number, etc. Preferably, the adjustment is made according to the concentration of multiple PCR amplification products in multiple rounds of test experiments, the total amount of products, and whether the number of reads of each amplicon given by the NGS data analysis results reaches 100 times the coverage, so as to ensure that the amplification efficiency of each pair of primers is equivalent and the coverage reaches 100 times, and over-amplification is not performed to avoid the reduction of detection accuracy due to the weakening of the difference of gene fragments with different copy numbers due to over-amplification.
[0030] In the present invention, by using samples with known positive CNV results and samples with negative CNV results, the experimental flow of the method of the present invention is used to conduct experiments, and the judgment criteria of positive and negative samples are obtained by bioinformatics analysis. Based on this, negative and positive sample baseline training sets are constructed, and the sequencing data is subjected to bioinformatics analysis and CNV baseline division. Preferably, the bioinformatics analysis uses ioncopy software, version number 2.2.2, and the judgment standard is that the bioinformatics analysis software calculates the CN value of each amplicon. Also preferably, a CN value ≥ 3.48 is positive. For each sample, the coverage of each amplicon is divided by the median of the coverage of all amplicons in the sample. For each amplicon, the coverage of each sample is divided by the median of the coverage of the amplicon in all samples, and then multiplied by 2. A CN value greater than 3.48 indicates an increase in the copy number. For the detection method of the present invention, as long as the CN values of 80% of the amplicons of a target gene are greater than 3.48, the target gene is judged to have an increase in copy number (CNV positive), otherwise, it is judged to be CNV negative.
[0031] Example
[0032] In this example, CDK4, CDK6, FGFR1, FGFR2, MET and HER2 are used as target genes for exemplary description.
[0033] 1. Design multiple pairs of evenly distributed PCR amplification primers for the upstream, midstream and downstream of the genomic sequence of the target gene. The specific sequences of the primers are shown in the table below.
[0034] Table 1 - Nucleotide primer sequence list
[0035]
[0036]
[0037] 2. The synthesized primer sequence powder is reconstituted to 100 μM with nuclease-free water, each primer is mixed in equal proportion, and the mixed primer pool is diluted with nuclease-free water. The concentration of each primer in the diluted primer pool is 0.04 μM.
[0038] 3. Perform multiple PCR amplification with primer pool and DNA extracted from clinical samples. The preparation of multiple PCR amplification reaction system is shown in the following table.
[0039] Table 2-PCR system
[0040]
[0041]
[0042] The multiplex PCR amplification reaction conditions are shown in the following table.
[0043] Table 3-PCR reaction conditions
[0044]
[0045] 4. The volume of the multiplex PCR product was made up to 50 μl with nuclease-free water, and 150 μl of XP magnetic beads were added for purification. The purified product was quantified using Qubit and the fragment size was detected using Agilent 2100.
[0046] 5. Take 50 ng of the purified PCR product for end repair. The configuration of the end repair system is shown in the following table.
[0047] Table 4-PCR reaction system
[0048] Components volume End Repair Buffer 7μl End repair enzymes 3μl Purified multiplex PCR products 50ng Nuclease-free water Make up to 60 μl Overall system 60μl
[0049] The reaction conditions for end repair are shown in the table below.
[0050] Table 5 - PCR reaction conditions
[0051]
[0052] 6. Connect the end repair reaction mixture to the sequencing adapter. The system configuration of the adapter connection is shown in the following table.
[0053] Table 6-Connection system
[0054] Components volume End repair reaction mixture 60μl Nuclease-free water 5μl Adapter Ligation Buffer 30μl Adapter ligase 10μl Double-ended with Index connector 1.5μl Overall system 106.5μl
[0055] The reaction conditions for the linker connection are shown in the following table.
[0056] Table 7 - Ligation reaction conditions
[0057]
[0058] 7. Add 82.5 μl of XP magnetic beads to the adapter ligation product for purification.
[0059] 8. The purified ligation product is PCR amplified using library amplification primers to form a sequencing library. The configuration of the PCR amplification reaction system is shown in the following table.
[0060] Table 8-PCR reaction system
[0061] Components volume Purified adapter ligation product 20μl 2X PCR Master Mix 25μl Phosphorylated P5 Primer (10 μM) 2.5μl P7 Primer (10μM) 2.5μl Overall system 50μl
[0062] The specific conditions for PCR amplification reaction are shown in the following table.
[0063] Table 9 - PCR reaction conditions
[0064]
[0065] 9. Add 50 μl of XP magnetic beads to the library for purification. The purified library is quantified using Qubit and the library fragment size is detected using Agilent 2100.
[0066] 10. The library is sequenced.
[0067] Example 2
[0068] This example is about the optimization of the optimal annealing temperature and the optimal number of amplification cycles.
[0069] According to the system in Table 10 and Table 12 below, the optimal annealing temperature and the optimal total amplification cycle number of multiple PCR amplification were tested, and the annealing temperature was tested at 62°C and 67°C, respectively, and the total amplification cycle number was tested at 25 cycles and 20 cycles, respectively. After the reaction was completed, the end repair and sequencing adapter connection were performed for high-throughput sequencing. The data analysis results of high-throughput sequencing and the interpretation criteria of CNV results (positive: tumor cell ratio ≧20% and the ratio of the number of amplified segments to the total number of segments ≧80%; negative: the ratio of the number of amplified segments to the total number of segments ≦40%; verification by a third-party technology platform is required: the ratio of the number of amplified segments to the total number of segments is between 40%-80%) show that the optimal annealing temperature is 67°C and the optimal total amplification cycle number is 20 cycles.
[0070] The annealing temperature before optimization was 62°C, and the total number of amplification cycles was 25 cycles.
[0071] Table 10-PCR amplification system
[0072]
[0073] Compared with the results of hybridization capture technology and ddPCR verification, the consistency of CNV detection in tumor FFPE samples by this method was 83.3% (5 / 6), which may be related to background baseline deviation caused by amplification preference and over-amplification. The specific results are shown in Table 11 below. Sample No. 2 is a sample with inconsistent test results.
[0074] Table 11 - Test results
[0075]
[0076] The optimized annealing temperature was 67°C and the total number of amplification cycles was 20.
[0077] Table 12-PCR amplification system
[0078]
[0079]
[0080] Compared with the results of hybridization capture technology and ddPCR verification, the detection consistency of this method was significantly improved. The consistency of CNV detection in tumor FFPE samples was 100% (6 / 6). The specific results are shown in Table 13 below.
[0081] Table 13 - Test results
[0082]
[0083] Although the present invention has been described with reference to exemplary embodiments, it should be understood that the present invention is not limited to the disclosed exemplary embodiments. Various adjustments or changes may be made to the exemplary embodiments of the present specification without departing from the scope or spirit of the present invention. The scope of the claims should be based on the broadest interpretation to cover all modifications and equivalent structures and functions.
Claims
1. Use of the reagent in preparing a kit for detecting a copy number variation of a target gene in a sample, characterized in that: The reagents include a primer set, and the detection includes the following steps: (1) selecting a genomic sequence corresponding to a target gene, designing multiple pairs of primers with evenly distributed target regions of 75-150 bp for the genomic sequence, and forming a primer set consisting of the multiple pairs of primers, wherein each primer in the primer set does not contain a modification and / or a label, wherein the genomic sequence includes an upstream sequence, a downstream sequence, and an exon and / or intron sequence of the target gene, wherein the upstream sequence includes a region extending 1-50 bp from the start codon of the target gene to the 5' side, and the downstream sequence includes a region extending 1-50 bp from the stop codon of the target gene to the 3' side; (2) constructing a multiplex amplification reaction system using the primer set, optimizing the reaction conditions, and obtaining multiplex amplification products, wherein the optimized reaction conditions include a first cycle and a second cycle; wherein the first cycle includes the step of repeating a high temperature reaction and a first low temperature reaction for n times, and the second cycle includes the step of repeating a high temperature reaction and a second low temperature reaction for m times, wherein n and m are 10 respectively, the high temperature refers to 95-99° C., the first low temperature refers to 67° C., and the first low temperature of each cycle in the first cycle is gradually reduced, and the second low temperature is the temperature corresponding to the nth cycle; (3) performing end repair on the obtained multiple amplification products, connecting sequencing adapters, amplifying by PCR, enriching and sequencing libraries for sequencing; (4) constructing negative and positive sample baseline training sets and analyzing sequencing data to obtain CNV baselines; and (5) Interpret the sequencing results based on the CNV baseline, The target genes and primers are as follows:
2. The method according to claim 1, wherein the reaction system comprises primers mixed in equal proportions.
3. The use according to claim 1, wherein the gene copy number variation includes the copy number change of the entire genomic region corresponding to the target gene.
4. The use according to claim 1, wherein the sample is peripheral blood, tumor FFPE sample or fresh tissue sample.
Citation Information
Patent Citations
DNA library construction method for high-throughput sequencing
CN106350590A
Primer combination, kit and method for detecting autosomal copy number variation
CN111304299A
